Skip to main content

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

Competition and Consumer Commission of Singapore
  1. Home
  2. Case Register
  3. Public Register
  4. Commitments and Remedies
  5. Acquisition of Innovative Diagnostics Private Limited and Quest Laboratories Pte Ltd by Pathology Asia Holdings Pte Ltd
Commitments and Remedies

Acquisition of Innovative Diagnostics Private Limited and Quest Laboratories Pte Ltd by Pathology Asia Holdings Pte Ltd

18 October 2019

This article has been migrated from an earlier version of the site and may display formatting inconsistencies.


Competition Law Case

Acquisition of Innovative Diagnostics Private Limited and Quest Laboratories Pte. Ltd. by Pathology Asia Holdings Pte. Ltd.

Parties Involved

  • Pathology Asia Holdings Pte. Ltd.

  • Innovative Diagnostics Private Limited

  • Quest Laboratories Pte. Ltd.


Focus of Commitments/ Remedies

The commitments work together to address the competition concerns identified by:

  • Helping competing laboratories offer a wider range of IVD tests and be better able to compete for customers, and gauge demand to consider in-house expansion;

  • Lowering contractual barriers for customers to switch to other suppliers, and increase competing laboratories’ incentives to expand; and

  • Mitigating the risk of a price increase or a degradation of quality by the merged entity during the commitment period, for customers who have limited alternatives to switch to at present.


Start Date of Commitments/ Remedies

18 October 2019

End Date of Commitments/ Remedies

17 October 2023

Back to top